The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Atara Biotherapeutics, Inc(NASDAQ:ATRA) 
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr viru...
Website: http://www.atarabio.com
Founded: 2012
Full Time Employees: 429
Sector: Healthcare
Industry: Biotechnology
Atara Biotherapeutics Days Payable Outstanding ttm (DPO)
Atara Biotherapeutics Days Receivable Outstanding ttm (DSO)
Atara Biotherapeutics Days Inventory Outstanding ttm (DIO)
Atara Biotherapeutics Op Cashflow Per Share ttm
Atara Biotherapeutics Free Cashflow Per Share ttm
Atara Biotherapeutics Cash Per Share ttm
Atara Biotherapeutics P/S ratio ttm
Atara Biotherapeutics (GAAP) P/E ratio ttm
Atara Biotherapeutics P/B ratio ttm
No extra charts and metrics for this ticker.